But what orders? Lots of talk about the contracts and very little sales with cash flow being burnt through a million a quarter. Still waiting for the full trial results, and FDA approval but management probably need to start drip feeding the market with a few announcements otherwise if there are none until December, this could still further retrace to sub 15 cents. Don't like to be a negative Nancy here, but I believe shareholders were hoping there would have been a lot more action over the past year, but instead have been left disappointed in the short term, watching any investment slowly dwindle. This one takes a lot of patience, but I think longer term if all goes according to plans, then this could really rocket. Time will tell. Good Luck to all though!
NTI Price at posting:
19.5¢ Sentiment: Buy Disclosure: Not Held
